Studies by a Duke Cancer Institute-led team have identified a mechanism that underpins how breast cancer cells use cholesterol to develop tolerance to stress, making them invulnerable as they spread from the tumor site. The findings showed that chronic exposure to the cholesterol metabolite, 27HC, effectively selects for cells that exhibit increased cellular uptake and/or biosynthesis of lipids, and these cells show much greater metastatic capacity.